NCT05079750View on ClinicalTrials.gov

A Study of a New Vaccine Against Two Types of Ebola

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 11, 2021

Primary Completion Date

March 21, 2023

Study Completion Date

March 21, 2023

Conditions
Ebola
Interventions
BIOLOGICAL

ChAdOx1 biEBOV

ChAdOx1 biEBOV provided as a liquid in glass vials and administered intramuscularly into the deltoid of the non-dominant arm (preferably)

Trial Locations (1)

OX3 7LE

Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT05079750 - A Study of a New Vaccine Against Two Types of Ebola | Biotech Hunter | Biotech Hunter